Hsu S M, Hsu P L
Department of Pathology, University of Arkansas for Medical Sciences, Arkansas Cancer Research Center, Little Rock.
Crit Rev Oncog. 1994;5(2-3):213-45. doi: 10.1615/critrevoncog.v5.i2-3.60.
The most recent sophisticated investigations have provided new and revealing but also contradictory and controversial informaiton on the biological nature and the cellular origin of Hodgkin and Reed-Sternberg (H-RS) cells. Immunophenotypic analyses have shown consistent expression of CD15, CD30, CD74, and HLA-Dr antigens, but generally lack of T- or B cell-associated markers in H-RS cells. The H-RS cells are also devoid of many monocyte/macrophage-associated antigens. Molecular genetic studies have demonstrated heterogeneous findings with respect to rearrangements of T-cell receptor and immunoglobulin genes. Only a small percentage of the cases have rearrangements; this cannot always be attributed to the threshold of sensitivity of the method and/or the scarcity of the malignant cells in tissues examined. The H-RS cells do not express transcription factors such as BSAP, TCF-1, and GATA-3, known to be associated with lymphoid cells. It appears that evidence to support a lymphoid origin for H-RS cells is still lacking. On the contrary, the mechanism responsible for the unique clinical and histopathologic alterations associated with this disease has become clear. The H-RS cells have been shown to secrete IL-1, IL-5, IL-6, IL-9, TNF-a, M-CSF, and TGF-b, and, less frequently, IL-4 and G-CSF. These cytokines are likely to be responsible for the increased cellular reaction and fibrosis observed in tissues involved by HD and for the immunosuppression in patients with HD. Like most lymphomas, the etiology or pathogenesis of HD remains unknown. The Epstein-Barr virus (EBV) genomes are clonally integrated in the H-RS cells of about half the cases. The significance of these findings, whether EBV is a causative agent or an epiphenomenon, remains to be elucidated.
最近的精密研究就霍奇金和里德-施特恩伯格(H-RS)细胞的生物学特性和细胞起源提供了新的、有启发性但也相互矛盾且存在争议的信息。免疫表型分析显示H-RS细胞持续表达CD15、CD30、CD74和HLA-Dr抗原,但通常缺乏T或B细胞相关标志物。H-RS细胞也缺乏许多单核细胞/巨噬细胞相关抗原。分子遗传学研究在T细胞受体和免疫球蛋白基因重排方面显示出异质性结果。只有一小部分病例存在重排;这并不总是能归因于方法的灵敏度阈值和/或所检查组织中恶性细胞的稀少。H-RS细胞不表达已知与淋巴细胞相关的转录因子,如BSAP、TCF-1和GATA-3。似乎仍缺乏支持H-RS细胞起源于淋巴细胞的证据。相反,与该疾病相关的独特临床和组织病理学改变的机制已变得清晰。已证明H-RS细胞可分泌IL-1、IL-5、IL-6、IL-9、TNF-α、M-CSF和TGF-β,较少分泌IL-4和G-CSF。这些细胞因子可能是导致HD累及组织中观察到的细胞反应增加和纤维化以及HD患者免疫抑制的原因。与大多数淋巴瘤一样,HD的病因或发病机制仍然未知。爱泼斯坦-巴尔病毒(EBV)基因组在大约一半病例的H-RS细胞中呈克隆性整合。这些发现的意义,即EBV是病原体还是一种附带现象,仍有待阐明。